Subscribe
migraine-head
ESB Professional / shutterstock.com
9 July 2020EuropeMuireann Bolger

Teva loses TM appeal over ‘French version’ of slogan

Drug company  Teva has lost an appeal over its bid to trademark two word signs, after the tenth chamber of the  EU General Court ruled in favour of the  European Union IP Office (EUIPO) yesterday, July 8.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Big Pharma
EIP hires Teva litigator
7 January 2014   EIP has hired IP litigator Matthew Jones from Teva Pharmaceuticals Europe as a partner.
Big Pharma
European Commission calls out Teva over anti-competitive practice
18 July 2017   The European Commission has called out Teva over anti-competitive behaviour centring on a pay-for-delay drug deal.
Big Pharma
Teva withdraws Shield patent oppositions
19 October 2020   Israeli generics company Teva has withdrawn its oppositions to two patents owned by Shield Therapeutics before the European Patent Office.


Editor's picks

Europe
UPC confirms validity of Edwards Lifesciences heart valve tech patent
23 July 2024

Editor's picks

Europe
UPC confirms validity of Edwards Lifesciences heart valve tech patent
23 July 2024
Americas
New-look WIPR Leaders 2024 is ‘most rigorous’ yet
2 July 2024
Americas
Earthquake Chevron: A massive shock to the system?
2 July 2024
Americas
Amarin wins appeal to advance ‘skinny label’ suit over Hikma generic
27 June 2024
Biotechnology
Guardant Health files suit against Tempus AI
13 June 2024
Big Pharma
Roche fires lawsuit at Sinocare unit over blood glucose test strip patents
6 June 2024

More on this story

Big Pharma
EIP hires Teva litigator
7 January 2014   EIP has hired IP litigator Matthew Jones from Teva Pharmaceuticals Europe as a partner.
Big Pharma
European Commission calls out Teva over anti-competitive practice
18 July 2017   The European Commission has called out Teva over anti-competitive behaviour centring on a pay-for-delay drug deal.
Big Pharma
Teva withdraws Shield patent oppositions
19 October 2020   Israeli generics company Teva has withdrawn its oppositions to two patents owned by Shield Therapeutics before the European Patent Office.

More on this story

Big Pharma
EIP hires Teva litigator
7 January 2014   EIP has hired IP litigator Matthew Jones from Teva Pharmaceuticals Europe as a partner.
Big Pharma
European Commission calls out Teva over anti-competitive practice
18 July 2017   The European Commission has called out Teva over anti-competitive behaviour centring on a pay-for-delay drug deal.
Big Pharma
Teva withdraws Shield patent oppositions
19 October 2020   Israeli generics company Teva has withdrawn its oppositions to two patents owned by Shield Therapeutics before the European Patent Office.

More features

Chinese biotech takes out US rival’s nucleic acid patent at PTAB
Lewis Roca promotes tech expert to managing partner
Panitch Schwarze brings in molecular biologist
US targets ‘product hopping’ with biologic litigation curbs
UPC confirms validity of Edwards Lifesciences heart valve tech patent
ITC concludes row over biotech lab equipment between US and German rivals
UKIPO launches ‘revolutionary’ patent filing and AI tool
USPTO clarifies AI's role in patent eligibility